10.1016/j.ejmech.2015.04.040 91 PizzinoG.IrreraN.CucinottaM.PallioG.ManninoF.ArcoraciV.et al (2017)
Research suggests GLP-1 medications may reduce certain inflammatory pathways directly, while also lowering inflammation indirectly through weight loss, improved insulin resistance, and reduced visceral fat
June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026
It is not FDA-approved and was flagged by the FDA as a safety risk for compounding
These combined effects make it easier to stick to a healthy eating plan and create the calorie deficit needed for weight loss
Immune System Boost: It strengthens the immune system by supporting white blood cell function and fighting off infections